Company patents

Veradermics, Incorporated

Veradermics, Incorporated's patent strategy is almost entirely focused on "Pharmaceutical Preparations" (100.0% of its portfolio) and "Therapeutic Activity (Pharma)" (95.5%), with both categories showing significant emerging focus, growing by +400.0% and +1400.0% respectively in 2025, and continuing strong growth so far in 2026 with +73.3% for both, indicating a rapid expansion in its core pharmaceutical R&D, while its "Drug Delivery Devices" category has seen a complete shift in priority, declining by -100.0% in 2025.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

88 US filings (since 2023) · 3 categories · 1 themes

Patents

Showing 1-10 of 89

Page 1 of 9